Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Henry

Showing results (1111-1120 of 1,163) with videos related to

Pageof 117
Sort By:
Science Translational Medicine|September 10, 2025
Functional, immunogenetic, and structural convergence in influenza immunity between humans and macaquesMaya Sangesland, Ning Li, Yaroslav Tsybovsky, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Cancer Cell|September 8, 2015
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant CancersSheng-Bin Peng, James R Henry, Michael D Kaufman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2006
Plant community responses to experimental warming across the tundra biomeMarilyn D Walker, C Henrik Wahren, Robert D Hollister, et al.
Global Change Biology|January 13, 2017
Greater temperature sensitivity of plant phenology at colder sites: implications for convergence across northern latitudesJanet Prevéy, Mark Vellend, Nadja Rüger, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.
Diabetes Care|February 8, 2019
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) InhibitorsThomas Danne, Satish Garg, Anne L Peters, et al.
Science Translational Medicine|February 25, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boostNoemia S Lima, Lauren McCormick, Samuel Li, et al.
Science Advances|October 5, 2022
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibodySanjeev Kumar, Anamika Patel, Lilin Lai, et al.
Pageof 117

Showing results (1111-1120 of 1,163) with videos related to

Sort By:
Pageof 117
Science Translational Medicine|September 10, 2025
Functional, immunogenetic, and structural convergence in influenza immunity between humans and macaquesMaya Sangesland, Ning Li, Yaroslav Tsybovsky, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Cancer Cell|September 8, 2015
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant CancersSheng-Bin Peng, James R Henry, Michael D Kaufman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2006
Plant community responses to experimental warming across the tundra biomeMarilyn D Walker, C Henrik Wahren, Robert D Hollister, et al.
Global Change Biology|January 13, 2017
Greater temperature sensitivity of plant phenology at colder sites: implications for convergence across northern latitudesJanet Prevéy, Mark Vellend, Nadja Rüger, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.
Diabetes Care|February 8, 2019
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) InhibitorsThomas Danne, Satish Garg, Anne L Peters, et al.
Science Translational Medicine|February 25, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boostNoemia S Lima, Lauren McCormick, Samuel Li, et al.
Science Advances|October 5, 2022
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibodySanjeev Kumar, Anamika Patel, Lilin Lai, et al.
Pageof 117